Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML

Therapy-related and more specifically radiotherapy-associated acute myeloid leukaemia (AML) is a well-recognized potential complication of cytotoxic therapy for the treatment of a primary cancer. The CBA mouse model is used to study radiation leukaemogenesis mechanisms with Sfpi1/PU.1 deletion and p...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Gráinne, Cruz-Garcia, Lourdes, Zyla, Joanna, Brown, Natalie, Finnon, Rosemary, Polanska, Joanna, Badie, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Carcinogenesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422620/
https://www.ncbi.nlm.nih.gov/pubmed/31646336
http://dx.doi.org/10.1093/carcin/bgz175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422620/
https://www.ncbi.nlm.nih.gov/pubmed/31646336
http://dx.doi.org/10.1093/carcin/bgz175

Ejemplares similares